What is the CVR number of Commit Biologics ApS?

Commit Biologics ApS is registered with CVR / Virk under CVR 42642649.

What is the gross profit of Commit Biologics ApS?

Commit Biologics ApS reported a gross profit of -DKK 23.4m in 2025.

Commit Biologics ApS employs 23 people as of the latest annual report.

Thomas Lars Andresen is the CEO of Commit Biologics ApS, in role since 2026.

Anker Gunvald Lundemose chairs the board of Commit Biologics ApS, in role since 2023.

Commit Biologics ApS's registered address is Universitetsbyen 81.

APSActive

CVR 42642649Universitetsbyen 81, 8000 Aarhus CResearch and experimental development on natural sciences and engineering· NACE 7210Est. 2021 · 4 years old23 employees

Actively employed in the business

Name	Role	Member since
Current (1)
TL Thomas Lars Andresen Chief Executive Officer	Chief Executive Officer	2026

Former (6)


HG Heidi Gytz Olesen Management	Management	2021 – 2022
MB Mikael Becher Lykkegaard Winkler Management	Management	2021 – 2022
NS Nick Stub Laursen Management	Management	2021 – 2023
DV Dennis Vestergaard Pedersen Management	Management	2021 – 2022
KR Krishna Reddy Polu Chief Executive Officer	Chief Executive Officer	2023 – 2025
MW Mikkel Wandahl Pedersen Chief Executive Officer	Chief Executive Officer	2025 – 2026

Non-executive oversight

Name	Role	Member since
Current (7)
EV Eva Van Overmeire Board of Directors	Board of Directors	2024
NS Nick Stub Laursen Board of Directors	Board of Directors	2022
TL Thomas Lars Andresen Board of Directors	Board of Directors	2026
PJ Pieter Jeroen Bakker Board of Directors	Board of Directors	2022
JS Janine Schuurman Board of Directors	Board of Directors	2024
AG Anker Gunvald Lundemose Chairman	Chairman	2023
RV Roderick Verhelst Board of Directors	Board of Directors	2022

Former (2)


KR Krishna Reddy Polu Board of Directors	Board of Directors	2023 – 2025
MW Mikkel Wandahl Pedersen Board of Directors	Board of Directors	2025 – 2026

Active legal owners

Shareholder	Type	Ownership	Votes	Registered
Novo Holdings A/S	Company	25–33.32%	25–33.32%	2026
Bioqube Factory Fund I CommV	Individual	25–33.32%	25–33.32%	2026
Commit Biologics Holding ApS	Company	15–19.99%	15–19.99%	2026
Korys Investments	Individual	15–19.99%	15–19.99%	2026
BioInnovation Institute Fonden	Company	5–9.99%	5–9.99%	2022
BII Holdings A/S	Company	5–9.99%	5–9.99%	2023

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.